microdosing glp-1 agonists Medications Microdosing GLP-1s: Does It Work?

About one in eight adults (12%) say that they are currently taking a GLP-1 drug such as Ozempic or Wegovy either to lose weight or treat a chronic condition, an increase from 18 months ago, though the high costs of the medications remain a concern, a new KFF Health Tracking Poll finds.

At the same time, both Lilly and Novo Nordisk made multi-billion dollar capital investments in expanding their manufacturing capacity to satisfy unrelenting patient demand, including pharmas largest M&A deal of the year, the $16.5Bn acquisition of CDMO Catalent by Novo Holdings, the controlling shareholder of Novo Nordisk

Prime Therapeutics conducted a two-year, real-world study to examine the clinical outcomes and cost when patients were using a GLP-1 drug for obesity treatment.

Read more about the new GLP-1 pill that outperformed oral semaglutide in a recent Phase III trial.

GLP-1 medications such as Ozempic may help lower the risk of certain cancers.